# A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy

> **NCT01561755** · PHASE4 · TERMINATED · sponsor: **David M. Simpson** · enrollment: 12 (actual)

## Conditions studied

- HIV-associated Myelopathy

## Interventions

- **DRUG:** Intravenous Immunoglobulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01561755
- **Lead sponsor:** David M. Simpson
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Difficulty with enrollment
- **Last updated:** 2018-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01561755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01561755, "A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01561755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*